Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)

• Hoofdauteurs: Tina Z. Khan (Auteur), Adam Hartley (Auteur), Dorian Haskard (Auteur), Mikhail Caga-Anan (Auteur), Dudley J. Pennell (Auteur), Peter Collins (Auteur), Mahmoud Barbir (Auteur), Ramzi Khamis (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2021-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

<b>Aims:</b> An abundance of epidemiological evidence demonstrates that elevated lipoprotein(a) (Lp(a)) represents a significant contributing risk factor towards the development of cardiovascular disease. In particular, raised Lp(a) may play a mechanistic role in patients with refractory...